Hymenolepis nana

In brief

What it is

Hymenolepis nana is a tapeworm, or cestode: a flat, ribbon-like parasitic worm that lives in the gut and grows as a chain of segments behind a small head. It is called the dwarf tapeworm because it is small. An officer of the Indian Medical Service described the worms in 1916 as white threads about 10 millimeters long, nearly always without their heads, and modern descriptions put adults at 2 to 4 centimeters; eggs taken from rats in India in 2021 measured about 48 by 36 micrometers, a micrometer being a thousandth of a millimeter ^3,4,27. The literature files it under two genus names, Hymenolepis and Rodentolepis, which matters to anyone searching for it ^1,18.

What sets it apart is that it needs no second animal. It is the only human tapeworm whose eggs, passed directly from one person to another, grow into a new adult worm in the gut; the pork tapeworm's eggs can also pass between people, but they grow only into larval cysts in the tissues ^2,5. It can complete its entire life cycle inside a single host ^2,5. People, mice and rats all carry it, and flour beetles and fleas can carry its larval stage ^5,6. Rodents carry it widely: pooled surveys from Iran found it in 13% of rodents and 19.6% of rats, and eggs turned up in 21.0% of cages of pet-shop and breeder rodents in Slovakia between 2016 and 2018 ^7,28.

Whether it is one species is no longer certain. Human and rodent worms look identical, but 51 human isolates from Australian communities produced no adult worms in mice, rats or hamsters in 2002, even in animals whose immunity had been suppressed with cortisone ²⁹. A 444-base stretch of one mitochondrial gene, from the small separate genome inside the cell's energy-producing structures, differed by about 5% between some mouse and human isolates (9 rodent and 6 human isolates were sequenced), which suggests a cryptic species complex, meaning several species that cannot be told apart by eye ³⁰. Its genome had been sequenced and assembled by 2019 ³¹.

Is it the most common tapeworm?

The owner's belief is that this is the most common tapeworm. That is right, with one honest qualification. Several peer-reviewed papers say so in plain words: a 2016 study from Peru opens with "Hymenolepis nana is the most common cestode infection in the world", a 2020 study from Yemen calls it the most common cestode reported in humans, and a 2019 molecular paper calls it the most prevalent human tapeworm ^5,23,31. The qualification is that these are statements in introductions, not the result of anyone counting the world. The usual figure, 50 to 75 million people, is repeated in a 2021 case report and a 2025 survey, while the Yemen paper says over 75 million; each cites the figure rather than deriving it ^5,8,9. The figure may trace to a 1999 review by D.W.T. Crompton that compiled worldwide estimates of worm infections, a compilation built from earlier surveys rather than a count ³⁶.

The comparison with other tapeworms points the same way. The fish tapeworm, Diphyllobothrium, was estimated in 2009 to infect up to 20 million people ³⁷. For Taenia tapeworms, which microscopy cannot tell apart, surveys across the Middle East and North Africa found 0.02% to 8.6%, most of it likely to be the beef tapeworm ³⁸. The one direct comparison on the same specimens is a 2020 German study of stool DNA, the genetic material, by quantitative polymerase chain reaction (PCR), a test that copies a target gene and counts the copies: dwarf tapeworm was found in 40 to 42 of 250 samples and Taenia in 1 to 4, although Taenia was the one target on which the platforms did not agree at all, with kappa below zero, so its count is itself uncertain ³⁹. Those samples were chosen because they were likely to be infected, so the figures rank the parasites rather than measure how common they are, and one of the authors works for a PCR reagent company ³⁹.

Where people look, they find it. A 2017 national survey in Sudan found it in 4.9% of 96,679 schoolchildren's stools, about 4.2% in the author's national estimate; the author's discussion puts the three soil-transmitted roundworms at only 0.1%, although the results give 0.1% as the share of dwarf tapeworm cases co-infected with them, and the author estimated about 2 million infected Sudanese ⁹. In 2024 it was found in 27.08% of 384 children in camps for displaced families in Mogadishu ⁴⁰. It is not common everywhere: pooled studies from Iran give 1.2% (95% confidence interval 1.0 to 1.4) ⁷. In Australia's Northern Territory it was the tapeworm most often identified by government laboratories from 2002 to 2013, nearly always in Indigenous children ⁴¹.

So the corrected sentence is this: in most of the surveys found for this page that count both, the dwarf tapeworm is found more often than any other tapeworm, and its global total is an estimate that nobody has measured ^9,23,39. US state laboratories in 1987 found it in 0.4% of stool specimens against 0.1% for Taenia ⁴², and a Cambodian survey of 2019 to 2021 found 1.09% against 0.54% ⁴³; some pooled figures put the two level, at 2.0% each among Iranian food handlers ⁴⁴. The distinction matters for how the claim is stated. "The most common human tapeworm in most surveys that count both" is accurate. "The most common tapeworm, infecting 75 million people" sounds the same but claims a count that does not exist, because the number is passed from paper to paper rather than derived ^5,9.

How you get it: a life cycle that needs no one else

Most tapeworms need two hosts: an intermediate host, in which the larva develops, and a definitive host, in whose gut the adult lives, as the pork tapeworm uses a pig and then a person ². The dwarf tapeworm can do both in one mammal. A swallowed egg hatches into an oncosphere, a larva with six hooks, which burrows into the intestinal wall; in mice it becomes an infective cysticercoid, a tiny larval cyst holding the future head, within about 4 days, then breaks back into the gut and grows into an adult ². The larva sits in the villi, the finger-like projections that line the small intestine: in a 1991 mouse study, eosinophils, white cells that respond to worms, gathered around cysticercoids in the villi ³².

There is a second route. Flour beetles and fleas carry cysticercoids, and swallowing an infected insect also infects ^5,6. Larvae that grow in beetles have tails and those that grow in mammals do not, which a 2021 review describes as unique among these tapeworms ². In people, the eggs travel hand to mouth and in food and water. In Yemen, the risk was higher in children under 6 (adjusted odds ratio 4.28), in the highlands (2.87), in those with an infected family member (2.48), without an improved toilet (2.19), or who did not wash vegetables (2.11) or their hands after the toilet (1.88) ⁵. An odds ratio compares the odds of infection in two groups; 2 means about double. Inadequate water and sanitation were the strongest factors in northern Peru, and schools appear to play a part in the highlands ^19,21.

Autoinfection is the parasite's signature: eggs released inside the gut can hatch and start new larvae without ever leaving the body, so one infection can multiply in place ^5,6. The experimental picture is more careful than the textbook one. In mice infected with eggs, immunity against new larvae develops within about 4 days and autoinfection does not occur; it is seen after infection with cysticercoids in some mouse strains, and adult worms usually shrink and disappear within about a month ². Autoinfection is how clinicians explain human infections that persist for years, but the detailed evidence for how it works comes mostly from mice ^2,8.

That immunity is why the heaviest infections occur when it fails. Mice born without a thymus, and so without the T cells it trains, showed no resistance to new larvae ³². A rodent that normally resists the worm carried it to egg-laying adults only while it was given dexamethasone, a corticosteroid, every day ¹⁸. Tacrolimus, a drug given to transplant patients, suppressed protective immunity in mice at the higher of two doses tested, 10 mg/kg but not 5 mg/kg ³³. In people the evidence is observational: a 27-year-old man in New Jersey with untreated acquired immunodeficiency syndrome (AIDS), the late stage of infection with the human immunodeficiency virus (HIV), a CD4 count of 93 cells per cubic millimeter and weeks of high-dose dexamethasone had worms visible at colonoscopy ⁸. Children carry it most for reasons that have been observed rather than proven: poorer hygiene, crowding in homes, day care centers and schools, and siblings who pass it to one another. In London, infections in families clustered among siblings rather than parents, and the Yemen author attributes the peak under age 6 to direct and family transmission ^3,5,21. In Australia's Northern Territory the median age at diagnosis was 3 years ⁴¹. In mice, a first infection leaves strong immunity within days ², which may be one reason infection falls with age, but this has not been measured in people. There is no single definition of a heavy infection: a 2025 case report calls more than 500 eggs per gram of stool hyperinfection, and a Peruvian study used the same figure as its cutoff for heavier infection ^6,23, while the Yemen survey classed only 10,000 or more eggs per gram as heavy ⁵. For this worm the word does not carry the life-threatening meaning it has for the roundworm Strongyloides.

What it does to you

Most infections are light and many cause nothing a doctor can pin on the worm. In rural Yemen, 81.6% of infections were light, and 72% of infected children carried other parasites too, so the author warned that symptoms could not be cleanly attributed ⁵. The strongest counter-evidence is a matched case-control study from northern Peru: 25 people with the infection and no other intestinal worm or Giardia reported no more symptoms than 46 matched controls, except headache, which was less frequent in the infected ²². A case-control study compares people who have a condition with similar people who do not.

Other studies find real associations. Among 1,230 children in the Cusco highlands, infection was associated with diarrhea, jaundice, headaches, fever and fatigue, and children shedding more than 500 eggs per gram were more likely to report weight loss, jaundice, diarrhea and fever ²³. In Yemen, infected children more often reported abdominal pain (39.1% against 27.7%), anal itching (39.1% against 27.0%) and dizziness (20.7% against 11.4%), but not diarrhea (21.8% against 17.3%, not significant) ⁵. In 511 Bolivian schoolchildren, infection was associated with anemia, odds ratio 2.9 (95% confidence interval 1.5 to 5.7) ²⁴. In the Northern Territory, 18.2% of laboratory-diagnosed episodes came with anemia and 39.6% with eosinophilia, an elevated count of the white cells that respond to worms ⁴¹. All of these are associations measured at one point in time, which cannot show that the worm caused the symptom.

In people whose immunity is suppressed, the infection can be serious. Physicians in California reported chronic diarrhea from it in an immunosuppressed patient, and the New Jersey patient with AIDS improved quickly after praziquantel ^8,50. In 2003, DNA analysis identified it as the cause of fatal "aberrant metastatic larval disease", larvae spreading through the body, in a patient with AIDS, very probably the man described in 1996 ^25,51. A 2025 report from India describes heavy infection found on stool testing after a child's death; the infection was an incidental finding and the report does not establish that it caused the death ⁶. Animals show the same capacity: a zoo lemur died of disseminated infection with liver and lung damage, and four captive Madagascan rodents had larvae in the liver, lymph nodes and beyond ^52,53.

One older association has not been followed up. In 1979, Egyptian physicians found its eggs in 62.6% of 471 patients with phlyctenular disease, small inflamed nodules on the surface of the eye, against 10.8% of controls, and proposed an allergic reaction to the larval stage ¹⁰. It was an association study, and no later test of it has been reported.

The full history

The dwarf tapeworm was found in Cairo in 1851 and named by Siebold the next year, and within two generations it had been recorded in Europe, Asia, Africa and the Americas, including the United States ^10,27,54. Early treatments were plant extracts that expelled the body of the worm and left the head behind, so that the eggs came back within weeks ²⁷. By the early 1960s, niclosamide was in clinical trials against it ⁵⁵, and in 1980 a single dose of a new drug, praziquantel, cured 98.5% of children at the right dose ¹⁵.

The modern history is a series of corrections. Infection experiments and molecular methods suggested that the worm in people may not be the same as the worm in mice ^29,30, showed that it is not the only hymenolepidid, a member of its family, the Hymenolepididae, that infects people ⁵⁶, and re-identified the parasites in two lethal invasive infections in immunosuppressed patients: one as the dwarf tapeworm and the other as an uncharacterized larval cestode rather than a sparganum ²⁵, later assigned to Versteria, a tapeworm of the weasel family ⁵⁷. In 2015 came the case that changed what a tumor can be ¹⁷. Meanwhile American laboratories moved toward stool panels that do not look for worms at all ^12,13,20.

How it is found, and whether American hospitals look

The test that finds it is the ova-and-parasites exam, or O&P: a technologist examines stool under the microscope for eggs, larvae and cysts, usually after concentration, in which the stool is mixed with chemicals and spun so that eggs collect in a small pellet. Formalin-ethyl acetate concentration, one of the standard ways of concentrating stool for an O&P, found the dwarf tapeworm in 10 of 1,521 samples in Iran, and DNA sequencing confirmed all 10 ¹¹. In Upper Egypt, three ordinary microscopy methods found it in 28.3% of children with diarrhea, and PCR confirmed every result ⁴⁵. Its eggs are recognizable: in rats, smaller oval eggs with four to eight thread-like polar filaments, about 48 by 36 micrometers, against the larger, filament-free eggs of the rat tapeworm, Hymenolepis diminuta, which also infects people and which albendazole and mebendazole did not clear in the reported cases ^4,67. The work is manual and depends on experience ⁶⁸.

No single test catches everything. In 1,083 Peruvian children with three samples each, Kato-Katz found 77.7% of the dwarf tapeworm infections that all tests together found, and the Lumbreras rapid sedimentation method, in which stool settles in a tube of water so that eggs sink to the bottom, found 97.9% ⁴⁹. At Massachusetts General Hospital, 91% of the parasites detected were found in the first specimen, but most evaluations sent only one; when three or more were sent, the first specimen detected 72% of infections, and the authors judged one comprehensive O&P enough for most patients where up to 20% of those tested are infected ⁶⁹. Where DNA tests are used, commercial and in-house PCR platforms agreed closely on the dwarf tapeworm, though without a gold standard to measure accuracy against, and a marketed helminth panel detected it once stool was mechanically broken up first ^39,65. A 2026 study of an artificial-intelligence reader for O&P slides, a commercial product, reported 96.62% agreement on positives after review by a technologist ⁷⁰.

The owner believes that American hospitals never check for it. That is not correct, and the correction is worth having precisely. American laboratories have long relied on the O&P: at a national US referral laboratory from 1997 to 2006, 76.0% of 170,671 parasite-testing episodes included one ⁷¹. In 1987, state diagnostic laboratories reported its eggs in 0.4% of 216,275 stool specimens, four times the rate for Taenia ⁴². American hospitals have found the dwarf tapeworm, at Olive View-UCLA Medical Center in California, at Rutgers in New Jersey and at the National Institutes of Health, where it turned up on a screening colonoscopy ^8,50,72.

What is right in the belief is narrower and more useful. The fast multiplex stool panels used in US hospitals, single cartridges that test one sample for DNA from a fixed list of germs in about an hour, cannot find it. The 22 targets of one panel evaluated in 2015, the BioFire FilmArray GI panel, include four parasites, all of them protozoa, single-celled organisms rather than worms; four of that evaluation's authors worked for its manufacturer, and the panel was FDA-cleared in May 2014 ^12,14. The other, also an FDA-cleared product, meaning cleared by the Food and Drug Administration for marketing as a diagnostic test, was cleared for 11 pathogens, two of them parasites ¹³. A worm that is not a target cannot be detected at any level. Over the past decade many US hospitals have moved toward these panels, which have started to replace culture and the O&P ^20,73. The O&P is also ordered for few patients in some settings: at a Boston children's hospital it was sent for 10% of 1,381 transplant recipients, and 2 of 242 tests were positive ⁷⁴. Across 37 US children's hospitals from 2016 to 2020, among otherwise healthy children with acute gastrointestinal infections, an O&P was sent for fewer than 10% of those hospitalized, but the rate ranged from 0% to 35.1% from one hospital to the next ⁷³. In Europe, by contrast, a CE-marked cartridge panel with 26 targets, worms included, replaced microscopy for screening at a London hospital laboratory in October 2022 and detected the dwarf tapeworm in 6 samples that microscopy had called negative ^3,26.

When should an American doctor order an O&P? The governing documents are the 2017 Infectious Diseases Society of America guideline on infectious diarrhea and the joint laboratory guide updated in 2024 ^66,75. As summarized by a 2023 study of 37 US children's hospitals, the 2017 guideline strongly recommends stool testing for diarrhea with fever, bloody or mucoid stools, severe abdominal cramping or tenderness, or signs of sepsis, aimed at germs that antibiotics can treat, and many current guidelines advise against an O&P for diarrhea of less than 7 days without high-risk features ⁷³. One of the 2024 guide's authors lists a diagnostics company as affiliation ⁶⁶. Utah laboratory physicians recommended in 2011 that an O&P be reserved for patients with persistent symptoms after a negative antigen test, a quick test for a germ's proteins, or with a particular risk of parasites other than Giardia and Cryptosporidium, a description that would fit a child from an endemic area, a place where the infection is regularly present, or an immunosuppressed patient ⁷¹.

• Ova-and-parasites exam (O&P), with concentrationStool is concentrated and examined under the microscope for eggs; the dwarf tapeworm's eggs are small, oval and carry thread-like polar filaments ^4,11.The standard American parasite test; included in 76.0% of 170,671 parasite-testing episodes at a national US referral laboratory, 1997 to 2006 ⁷¹Formalin-ethyl acetate concentration found it in 10 of 1,521 samples, and sequencing confirmed all 10, which shows the positives were real but not how many were missed ¹¹. For parasites in general at one Boston hospital, a single specimen detected 72% of infections when three or more specimens were sent ⁶⁹.Infections missed on a single sample: the northern Peru authors call their single-sample 7.61% an underestimate ¹⁹. It also depends on the technologist's experience ⁶⁸.
• Kato-Katz thick smearA measured smear of stool, read for eggs per gram; the method of large field surveys such as Sudan's ⁹.Field surveys and deworming programs, not American hospital laboratories ^9,35Found 77.7% of dwarf tapeworm infections in 1,083 Peruvian children, against 97.9% for a sedimentation method, with all tests combined as the reference ⁴⁹.About one infection in five in that study; the authors expect it to miss more as deworming lowers egg counts ⁴⁹.
• Multiplex molecular stool panelOne cartridge tests a stool sample for DNA from a fixed list of germs in about an hour ¹².Hospital laboratories, as a rapid alternative to culture, antigen tests and microscopy; the two panels evaluated in 2014 and 2015 are both FDA-cleared ^12,13,14Not applicable to this worm, which is not a target. For its own 22 targets, specificity, the share of uninfected samples correctly called negative, was at least 97.1% ¹².Every worm, this one included: its parasite targets are protozoa only ^12,13.
• Stool PCR for helminthsLaboratory-developed and commercial DNA tests that do include Hymenolepis ^39,65.Research and some European laboratories ^39,65Agreement between PCR platforms on the dwarf tapeworm fell in the 'almost perfect' band, a kappa (an agreement score corrected for chance, where 1 is perfect) above 0.80, in samples with no gold standard; this is agreement between tests, not accuracy ³⁹.It missed 1 of 21 positive samples until the stool was mechanically broken up first ⁶⁵.
• Broad DNA testing and staining of a biopsyPCR that asks what organism is present in tissue, followed by antibody stains and probes that mark the cells in place ^17,51.When a tumor or lesion cannot be classified; it identified the 1996 case (named in 2003) and the 2015 case ^17,25,51A 2023 Swiss validation of a real-time PCR for larval tapeworm infections in biopsy and cytology samples detected Hymenolepis species among other larval tapeworms, and for its main targets had a lower detection limit than conventional PCR ⁹³; in the 2015 case, broad PCR identified tapeworm DNA in cells unrecognizable as tapeworm ¹⁷.Everything it is not asked to look for: it is run only when someone suspects a non-human cause ¹⁷.

What is done about it

Praziquantel is the treatment of choice, given as a single dose of 25 mg per kilogram ^5,59. One dose does not always work. At a London refugee health service, 9 of 21 stool samples checked at least a month after a single 30 mg/kg dose were still positive, 43%, from 7 patients, all of them children; failures cleared with repeat or supervised doses, including two doses 7 days apart, and with treatment of the whole family, and reinfection in crowded households could not be separated from drug failure ³. In treatment studies, it cured 98.5% of children at 25 mg per kilogram in 1980, 91.1% to 97.7% of Egyptian children in 1991, and 96% in the one randomized comparison, in Peru in 2000 ^15,16,34. Nitazoxanide, used against both protozoa and worms, cured 82% in that comparison and 75% of 20 people in a Peruvian field study ^16,22,76. Niclosamide, the older tapeworm drug, treats most intestinal tapeworms in a single dose, but against this one it is given for 5 to 7 days, and in mice it was the least effective of three drugs ^58,59,77,78. In the United States, praziquantel is approved for blood and liver flukes and nitazoxanide for diarrhea caused by Giardia and Cryptosporidium, so both are used off-label against this worm, and niclosamide is not available for people ^59,79,80.

The deworming programs that reach most children do not reliably reach this parasite. Mebendazole, a staple of those programs, cured 50% to 59% of children, against 91% to 98% for praziquantel ³⁴. In the Bolivian Chaco, years of mebendazole left the dwarf tapeworm as the most common worm, and in Afghanistan 6.8% of pupils carried it after years of deworming ^24,35. In Australia's Northern Territory its rate did not change between 2002 and 2013, despite deworming programs, a result the authors had predicted because albendazole does not eradicate it ⁴¹. In Sudan, praziquantel is given out where schistosomiasis is common, and the author estimated that about 1.1 million infected adults lived where it was not offered ⁹. In Bolivia, three yearly rounds of stool testing, with nitazoxanide for every child found infected, were followed by a fall in infection from 9.0% to 3.4%, in repeated surveys with no comparison group ⁷⁶.

In Yemen, children under 6 carried the most infections, and a child-friendly praziquantel, arpraziquantel, is now being introduced for schistosomiasis in that age group ^5,81. No study of it against the dwarf tapeworm has been reported. Prevention is ordinary, and the surveys point the same way: improved (not merely any) latrines, handwashing, washed vegetables, and treating infected family members are associated with less infection ^5,9,19.

The 2015 case: a tapeworm's cancer in a man

The case was published in the New England Journal of Medicine in November 2015 by pathologists at the Centers for Disease Control and Prevention in Atlanta, with clinicians in Medellín, Colombia, and parasitologists in Japan and London ¹⁷. Biopsies of a lymph node and of the lung of a man infected with HIV showed nests of monomorphic, undifferentiated cells, meaning cells that all looked alike and had no specialized features. Their appearance and invasive behavior were characteristic of cancer, but their small size suggested they were not human ¹⁷. He was 41, had been diagnosed with HIV in 2006 and was not taking his treatment, and his most recent CD4 count was 28 cells per cubic millimeter; the molecular diagnosis came 72 hours before he died, and no specific treatment was attempted ¹⁷.

Three methods identified them. A PCR assay targeting eukaryotes, organisms whose cells have a nucleus, found dwarf tapeworm DNA. Immunohistochemistry, staining with antibodies, and probe hybridization, in which labeled DNA or RNA binds its match inside the tissue, marked the cells themselves, although they were unrecognizable as tapeworm tissue. Comparative deep sequencing, reading the parasite's DNA many times over against a reference, found structural genomic variants, large rearrangements of the genome, "compatible with mutations described in cancer" ¹⁷. The authors concluded that invasion of human tissue by abnormal, proliferating, genetically altered tapeworm cells is a novel disease mechanism that links infection and cancer ¹⁷.

What it shows is narrow and real: in one man with HIV, tapeworm cells grew and invaded like a cancer, with the appearance and behavior of one, and only their small size hinted to the pathologists that they might not be human ¹⁷. What it does not show is equally important. It does not show that the dwarf tapeworm causes human cancer, because the cancer was not made of the man's cells. One case cannot say how often this happens. "Compatible with" stops short of proving that the variants drove the growth, and the abstract describes the cells as monomorphic, alike in appearance; it does not say whether they were monoclonal, descended from a single cell, which is a genetic claim ¹⁷.

It was not the first tumor-like tapeworm infection, only the first in which the cells were shown to carry cancer-like genomic changes ¹⁷. In 1996, a man with HIV died of an abdominal mass suggestive of a neoplasm, an abnormal growth of tissue, that invaded his liver; DNA from the tissue pointed to an unknown tapeworm ⁵¹. In 2003, a group that included three of the 1996 authors re-examined a fatal case of spreading larvae in a patient with AIDS, very probably the same man, and named the dwarf tapeworm as the cause ^25,51. Peter Olson, a parasitologist at the Natural History Museum in London, is an author of all three papers ^17,25,51.

Afterward, the journal published a letter from a Harvard zoologist and the authors' reply in March 2016 ^61,62. A 2015 commentary set the case beside the virus-driven cancers that HIV makes more common ⁸³. No second human case of transformed tapeworm cells had been reported in PubMed by early October 2026. The nearest human reports since 2015 are invasive, tumor-like larval infections with a different tapeworm, Versteria, in a kidney-transplant recipient from Atlantic Canada and in other patients, typically immunosuppressed; none was shown to involve transformed cells ^57,64,84. In animals, a zoo lemur's parasite was full of small round cells of highly unusual appearance, and four captive rodents had larvae spread through their organs ^52,53. The proliferating larva of another tapeworm, Sparganum proliferum, is a separate disease, and its reviewers warn that some old cases turned out to be the wrong tapeworm, which is why sequencing is required ⁸⁵.

How it connects to parasites and cancer

Measured against the parasites that do cause cancer, the dwarf tapeworm's link is thin. The International Agency for Research on Cancer reviewed biological carcinogens in 2012, and the PubMed indexing of that volume names three parasitic infections, all caused by flukes, and no tapeworm ⁸⁶. Of the 2.2 million cancers attributed to infection worldwide in 2018, the leading causes were Helicobacter pylori, human papillomavirus and the hepatitis B and C viruses ⁸⁷.

The human evidence for this parasite is one case of its own cells transforming, and one earlier fatal case of invasive dwarf tapeworm larvae, in a man with AIDS, described in 1996 and, very probably the same case, identified in 2003, that was not shown to be cancer ^17,25,51. The 2003 paper's second case, once called a sparganum, has since been assigned to a different tapeworm ⁵⁷. No study measuring cancer risk in people infected with it was found. The only controlled experiment points the other way: mice infected before a carcinogen was painted on their skin developed fewer and smaller tumors, in 4 groups of 14, with more eosinophils and neutrophils, two kinds of white blood cell, in the infected animals ⁶³. That is animal evidence of protection against chemically induced tumors, not evidence about people.

There is a biological reason the 2015 case is possible at all. Tapeworms grow from a reserve of undifferentiated cells: in a related tapeworm, these germinative cells are the only cells that divide ⁸⁸. Tapeworm genomes have lost several genes that govern what stem cells become ⁸⁹. Which cell type the tumor arose from is not stated ¹⁷, so this is plausibility, not explanation. The worm also acts on its host's own dividing cells. In mice in 2024 and 2025, its antigens and secretions increased the proliferation and differentiation of intestinal stem cells, and two of the studies found that they eased chemically induced colitis ^90,91,92; these are mouse findings about repair, not evidence about cancer in either direction.

For this season's question, the dwarf tapeworm matters less as a cause of cancer than as proof that a parasite can hide inside what looks like a cancer. In 1996 and in 2015, the lesion behaved like a tumor and its tissue looked unusual but could not be identified; only a broad DNA test that asked what organism was present named a tapeworm ^17,51. That is a strong argument that some parasite-related tumors could be missed by methods that never ask the question, and no argument at all that they are common.

What was believed and is not

Most of what changed about this parasite changed because someone looked with a new tool. DNA sequencing suggested that one species may be several look-alikes, found a second hymenolepidid in a Tibetan woman, and re-identified the tapeworms in two fatal invasive infections ^25,30,56, one of them since assigned to a different tapeworm altogether ⁵⁷. Broad DNA testing of a biopsy then found the one case in which the worm's own cells behaved like a cancer ¹⁷. Field surveys did the rest, by showing that the worm outlasts the deworming drugs aimed at roundworms ^24,41.

Two of the ten beliefs below are the show owner's, and both deserve a precise answer rather than a yes or a no. The dwarf tapeworm is found more often than other tapeworms in most surveys that count both, but no one has counted the world ^9,23,42. American laboratories do look for it with the microscope, but the US stool panels that have begun to replace the microscope in some hospitals cannot see it ^12,20,71. The other eight are the field's, and each is marked with when and how it changed.

What is still unknown

How many people carry it. There is no counted global estimate: published papers give 50 to 75 million or over 75 million without saying where the number came from ^5,9. There is no current American prevalence. The last national count is from 1987: state diagnostic laboratories found its eggs in 0.4% of 216,275 stool specimens, and Taenia in 0.1%; those were specimens sent in for testing, not a random sample of Americans ⁴². Since then the US evidence is case reports ^8,50,72.

How often American medicine misses it. No study was found that measures dwarf tapeworm infections missed after laboratories adopted multiplex panels. The newest national data on O&P use, from US children's hospitals in 2016 to 2020, show it is sent for a minority of children and very unevenly between hospitals ⁷³. The FDA-cleared US stool panels evaluated in the literature target single-celled parasites only ^12,13,14; in Europe, a CE-marked molecular panel that includes worms already detects it ^3,26.

Whether the 2015 tumor was monoclonal, descended from a single tapeworm cell, is not stated in its abstract ¹⁷, and what the two letters that followed argued is not indexed ^61,62. Whether tapeworm cells transform in other immunosuppressed patients is unknown, because no one has published a search of archived, unclassifiable tumors with the broad DNA tests that found the 1996 and 2015 cases ^17,25,51.

What the parasite is, and how best to treat it in the patients most at risk. The species complex has not been resolved ^30,56. The treatment trials were done in children in endemic areas, not in people with AIDS or transplants, and the new pediatric praziquantel has been studied for schistosomiasis, not for this worm ^15,16,81. Whether praziquantel reaches the larvae inside the human intestinal wall has not been measured; in mice it had little effect on larvae in a dish and yet worked best in the living animal ⁷⁸. How often single-dose failure is reinfection rather than drug failure is unknown ³.

Where it connects

Sources

93 sources, numbered as they are cited. Every one was checked against PubMed or its publisher before it was cited here; the note under each says what it shows and what it does not.

1. 1
   Thompson RCA. Neglected zoonotic helminths: Hymenolepis nana, Echinococcus canadensis and Ancylostoma ceylanicum.Clin Microbiol Infect · 2015 · 21(5):426-32doi:10.1016/j.cmi.2015.01.004 · PMID 25743998

   A review that names the parasite Hymenolepis (Rodentolepis) nana and argues it is a neglected zoonosis. Review, no new data.

2. 2
   Ito A, Budke CM. Perspectives on intestinal tapeworm infections: An evaluation of direct and indirect life-cycles with a special emphasis on species of [Hymenolepis].Curr Res Parasitol Vector Borne Dis · 2021 · 1:100023doi:10.1016/j.crpvbd.2021.100023 · PMID 35284891

   The review of the direct life cycle, read in full: larvae develop in mouse intestinal tissue within 4 days, immunity to reinfection follows within days, and immunodeficient mice let larvae spread to the liver. Almost all of it is mouse work. PubMed strips the genus from the title.

3. 3
   Killington K, Longley N, Bowers K, et al. Incidence of Rodentolepis nana infection within people seeking asylum and refugees attending health screening at an integrated refugee health service.BMC Glob Public Health · 2025 · 3(1):45doi:10.1186/s44263-025-00159-5 · PMID 40361196

   Read in full. A London refugee health service, 2016 to 2023: 54 of 1,797 screened (3%) positive; adults described as 2 to 4 cm long and 1 mm wide; single 30 mg/kg praziquantel doses, with 9 of 21 clearance samples (43%) still positive at least a month later, from 7 patients, all children; infection clustered among siblings rather than parents; the laboratory replaced microscopy with the CE-marked Novodiag panel in October 2022, which found 6 of 31 positives that microscopy called negative. Retrospective and small; reinfection and drug failure could not be separated.

4. 4
   Brar SK, Singla N, Singla LD. Comparative Comprehensive Analysis on Natural Infections of [two Hymenolepis species; names omitted in the PubMed record] in Commensal Rodents.Helminthologia · 2021 · 58(3):248-262doi:10.2478/helm-2021-0027 · PMID 34934388

   Egg measurements from Indian rats: smaller oval eggs with 4-8 polar filaments, about 48 by 36 micrometers, against larger eggs without them. PubMed strips the species names; the assignment of the smaller egg to the dwarf tapeworm follows the polar filaments the abstract describes.

5. 5
   Al-Mekhlafi HM. The Neglected Cestode Infection: Epidemiology of [Hymenolepis nana] Infection Among Children in Rural Yemen.Helminthologia · 2020 · 57(4):293-305doi:10.2478/helm-2020-0038 · PMID 33364898

   498 Yemeni children examined by three microscopy methods: 17.5% infected, highest under age 6, with risk factors and symptom comparisons; the full text was read. PubMed strips the species name from the title. The Discussion gives 15.5%, an internal inconsistency; 87 of 498 is 17.5%.

6. 6
   Mohod S, Bhise S, Dwivedi S, Chaturvedi A. A neglected zoonotic helminth- Hymenolepis nana, fatal in the pediatric population-an incidental finding.Indian J Pathol Microbiol · 2025 · 68(4):839-841doi:10.4103/ijpm.ijpm_783_24 · PMID 40485467

   A child's death in which heavy infection was found on postmortem stool testing; it restates the hyperinfection threshold and the routes of transmission. The title says fatal, but the abstract does not establish the cause of death.

7. 7
   Goudarzi F, Mohtasebi S, Teimouri A, et al. A systematic review and meta-analysis of Hymenolepis nana in human and rodent hosts in Iran: A remaining public health concern.Comp Immunol Microbiol Infect Dis · 2020 · 74:101580doi:10.1016/j.cimid.2020.101580 · PMID 33260017

   The only formal meta-analysis found: pooled human prevalence in Iran 1.2%, rodents 13%. It shows the parasite can be uncommon in people even where rodents carry it.

8. 8
   Patel R, Dellatore P, Smith C, Patel AV. [Hymenolepis nana] Infection in an HIV Patient With Diarrhea.ACG Case Rep J · 2021 · 8(11):e00709doi:10.14309/crj.0000000000000709 · PMID 34841004

   A New Jersey case, read in full: a 27-year-old man with untreated AIDS on high-dose steroids, worms seen at colonoscopy, eggs in stool, and symptoms rapidly improved after praziquantel (no follow-up stool test reported). One case; the steroid explanation is the authors' inference. PubMed strips the species name from the title.

9. 9
   Jin Y. An integrated mass drug administration against hymenolepiasis and schistosomiasis in Sudan.Parasites Hosts Dis · 2025 · 63(1):87-94doi:10.3347/PHD.24056 · PMID 40045684

   A national survey of 96,679 Sudanese schoolchildren in 2017, read in full: 4.9% positive by Kato-Katz, far more than soil-transmitted worms, and many infected people outside praziquantel programs. Its 50-75 million global figure is cited, not measured.

10. 10
    Al-Hussaini MK, Khalifa R, Al-Ansary AT, et al. Phlyctenular eye disease in association with Hymenolepis nana in Egypt.Br J Ophthalmol · 1979 · 63(9):627-31doi:10.1136/bjo.63.9.627 · PMID 486380

    Dates the discovery to Bilharz in Cairo in 1851, and reports eggs in 62.6% of 471 patients with an inflammatory eye disease against 10.8% of controls. An association study; no confirmation was found.

11. 11
    Shahnazi M, Mehrizi MZ, Alizadeh SA, et al. Molecular characterization of [Hymenolepis nana] based on nuclear rDNA ITS2 gene marker.Afr Health Sci · 2019 · 19(1):1346-1352doi:10.4314/ahs.v19i1.6 · PMID 31148960

    Formalin-ethyl acetate concentration, one of the standard ways of concentrating stool for an O&P, found 10 of 1,521 samples positive, and all 10 were confirmed by sequencing. PubMed strips the species name from the title.

12. 12
    Buss SN, Leber A, Chapin K, et al. Multicenter evaluation of the BioFire FilmArray gastrointestinal panel for etiologic diagnosis of infectious gastroenteritis.J Clin Microbiol · 2015 · 53(3):915-25doi:10.1128/JCM.02674-14 · PMID 25588652

    Lists all 22 targets of the BioFire FilmArray GI panel (FDA-cleared May 2014 [88]); its four parasites are all protozoa, so no worm can be detected. Four authors were employees of the manufacturer.

13. 13
    Khare R, Espy MJ, Cebelinski E, et al. Comparative evaluation of two commercial multiplex panels for detection of gastrointestinal pathogens by use of clinical stool specimens.J Clin Microbiol · 2014 · 52(10):3667-73doi:10.1128/JCM.01637-14 · PMID 25100818

    The second panel was FDA-cleared for 11 pathogens, two of them parasitic; both panels found far more pathogens than routine methods. Its target menus are those of 2014. The FilmArray panel it compared was an uncleared prototype at the time of the study; it was cleared in May 2014 [88].

14. 14
    US Food and Drug Administration. 510(k) premarket notification K140407: FilmArray Gastrointestinal (GI) Panel, BioFire Diagnostics.FDA 510(k) database · decision 2 May 2014www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm?ID=K140407

    The clearance of the panel evaluated in [12], received 18 February 2014 and cleared 2 May 2014. The decision date was confirmed through indexed copies of the FDA record; the FDA page itself could not be opened from here.

15. 15
    Schenone H. Praziquantel in the treatment of Hymenolepis nana infections in children.Am J Trop Med Hyg · 1980 · 29(2):320-1doi:10.4269/ajtmh.1980.29.320 · PMID 7369452

    155 children treated with one dose of praziquantel at three strengths; 98.5% cured at 25 mg/kg. Not randomized against another drug.

16. 16
    Juan JO, Lopez Chegne N, Gargala G, Favennec L. Comparative clinical studies of nitazoxanide, albendazole and praziquantel in the treatment of ascariasis, trichuriasis and hymenolepiasis in children from Peru.Trans R Soc Trop Med Hyg · 2002 · 96(2):193-6doi:10.1016/s0035-9203(02)90301-9 · PMID 12055813

    The only randomized head-to-head found: praziquantel cured 96% and nitazoxanide 82% of hymenolepiasis. The record lists non-government support without naming the funder.

17. 17
    Muehlenbachs A, Bhatnagar J, Agudelo CA, et al. Malignant Transformation of Hymenolepis nana in a Human Host.N Engl J Med · 2015 · 373(19):1845-52doi:10.1056/NEJMoa1505892 · PMID 26535513

    The single human case: invasive, cancer-like cells in a man with HIV, identified as dwarf tapeworm by eukaryotic PCR, labeled in place, and carrying structural genomic variants 'compatible with' cancer mutations. It shows that one parasite's cells transformed in one host; it does not show that the parasite causes human cancer. The patient details used here (age 41, HIV diagnosed in 2006 and untreated, CD4 count 28, molecular diagnosis 72 hours before death) are from the article's case description as reproduced in search indexes; the NEJM page itself could not be opened from here, and what the full text says about clonality was not checked.

18. 18
    Vianna GJ, de Melo AL. Experimental infection and adaptation of Rodentolepis nana to the Mongolian jird Meriones unguiculatus.J Helminthol · 2007 · 81(4):345-9doi:10.1017/S0022149X07818566 · PMID 17845734

    A host that normally resists the worm carried it to egg-laying adults only while given a steroid daily. Animal evidence that corticosteroids open the door.

19. 19
    Vilchez Barreto PM, Gamboa R, Santivañez S, et al. Prevalence, Age Profile, and Associated Risk Factors for [Hymenolepis nana] Infection in a Large Population-Based Study in Northern Peru.Am J Trop Med Hyg · 2017 · 97(2):583-586doi:10.4269/ajtmh.16-0939 · PMID 28829724

    14,761 children: 7.61% infected on one stool sample, which the authors call an underestimate; water and sanitation were the strongest associations.

20. 20
    Axelrad JE, Freedberg DE, Whittier S, et al. Impact of Gastrointestinal Panel Implementation on Health Care Utilization and Outcomes.J Clin Microbiol · 2019 · 57(3):e01775-18doi:10.1128/JCM.01775-18 · PMID 30651393

    At a New York academic medical center, 9,402 patients tested with the FilmArray GI panel against 5,986 tested conventionally; its abstract states that multiplex panels have started to replace stool culture and the ova-and-parasites exam. One center, before-and-after design.

21. 21
    Tanabe MB, Caravedo Martinez M, Morales ML, et al. Geospatial Analysis of Hymenolepis (Rodentolepis) nana Infection Transmission in Schools among Children in Cusco, Peru.Am J Trop Med Hyg · 2025 · 112(5):1010-1016doi:10.4269/ajtmh.24-0615 · PMID 40068215

    2,961 children in 51 schools: median school prevalence 15%, and schools appear to play a part in transmission. Cross-sectional geography.

22. 22
    Chero JC, Saito M, Bustos JA, et al. Hymenolepis nana infection: symptoms and response to nitazoxanide in field conditions.Trans R Soc Trop Med Hyg · 2007 · 101(2):203-5doi:10.1016/j.trstmh.2006.04.004 · PMID 16814334

    The strongest counter-evidence on symptoms: 25 people infected with this parasite alone reported no more symptoms than 46 matched controls; nitazoxanide cured 75% of 20. Small.

23. 23
    Cabada MM, Morales ML, Lopez M, et al. Hymenolepis nana Impact Among Children in the Highlands of Cusco, Peru: An Emerging Neglected Parasite Infection.Am J Trop Med Hyg · 2016 · 95(5):1031-1036doi:10.4269/ajtmh.16-0237 · PMID 27672206

    1,230 children in highland Peru: 17.4% infected, and infection associated with diarrhea and other symptoms, more so above 500 eggs per gram. Cross-sectional and parent-reported, so it shows association, not cause. Its opening sentence is the most quoted 'most common cestode' claim.

24. 24
    Spinicci M, Macchioni F, Gabrielli S, et al. [Hymenolepis nana]—An Emerging Intestinal Parasite Associated with Anemia in School Children from the Bolivian Chaco.Am J Trop Med Hyg · 2018 · 99(6):1598-1601doi:10.4269/ajtmh.18-0397 · PMID 30298806

    After years of mebendazole, roundworms had nearly gone and the dwarf tapeworm was the most common worm; the infection was associated with anemia, odds ratio 2.9. PubMed strips the species name, which the title and indexing supply. Cross-sectional.

25. 25
    Olson PD, Yoder K, Fajardo L-G LF, et al. Lethal invasive cestodiasis in immunosuppressed patients.J Infect Dis · 2003 · 187(12):1962-6doi:10.1086/375357 · PMID 12792874

    Two fatal cases re-examined with 18S ribosomal DNA PCR: dwarf tapeworm as the cause of 'aberrant metastatic larval disease' in a patient with AIDS, and an unknown larval cestode in a patient with Hodgkin disease whose infection had been called a sparganum 30 years earlier. It does not claim that the cells were cancerous. Its first case is very probably the 1996 Lancet patient [47], and its uncharacterized second larva was assigned to Versteria in 2019 (Deplazes et al., PMID 31338294) [78].

26. 26
    Hartuis S, Lavergne RA, Nourrisson C, et al. The Novodiag Stool parasites assay, an innovative high-plex technique for fast detection of protozoa, helminths and microsporidia in stool samples: a retrospective and prospective study.Parasite · 2022 · 29:27doi:10.1051/parasite/2022026 · PMID 35550028

    The first clinical evaluation, in France, of a CE-IVD marked cartridge panel with 26 targets spanning protozoa, worms and microsporidia. Internally funded; the authors declare no conflict of interest. Few worm-positive samples were available to test.

27. 27
    Stewart FH. Hymenolepis Nana (Siebold) (The Dwarf Tapeworm) as a Parasite of Indian Soldiers.Ind Med Gaz · 1916 · 51(6):218-219PMID 29008098

    A 1916 report, read in full, that describes the worm, its eggs and the treatments of the day, and cites American counts from 1904 and 1910 that were not themselves retrievable.

28. 28
    Jarošová J, Antolová D, Šnábel V, et al. The dwarf tapeworm Hymenolepis nana in pet rodents in Slovakia-epidemiological survey and genetic analysis.Parasitol Res · 2020 · 119(2):519-527doi:10.1007/s00436-019-06565-7 · PMID 31848746

    Eggs in 21.0% of cages of pet-shop and breeder rodents. Shows a household route for exposure; no human cases are reported.

29. 29
    Macnish MG, Morgan UM, Behnke JM, Thompson RCA. Failure to infect laboratory rodent hosts with human isolates of Rodentolepis (= Hymenolepis) nana.J Helminthol · 2002 · 76(1):37-43doi:10.1079/joh200198 · PMID 12018194

    Fifty-one human isolates from Australia produced no adult worms in mice, rats or hamsters, even with cortisone. Evidence that the human worm there was not the rodent worm; it does not settle the question everywhere.

30. 30
    Macnish MG, Morgan-Ryan UM, Monis PT, et al. A molecular phylogeny of nuclear and mitochondrial sequences in Hymenolepis nana (Cestoda) supports the existence of a cryptic species.Parasitology · 2002 · 125(Pt 6):567-75doi:10.1017/s0031182002002366 · PMID 12553576

    About 5% mitochondrial difference between some mouse and human isolates: the dwarf tapeworm is probably a complex of look-alike species. Small number of isolates.

31. 31
    Macchiaroli N, Cucher M, Kamenetzky L, et al. Identification and expression profiling of microRNAs in Hymenolepis.Int J Parasitol · 2019 · 49(3-4):211-223doi:10.1016/j.ijpara.2018.07.005 · PMID 30677390

    Molecular work that states the dwarf tapeworm genome has been sequenced and assembled and calls it the most prevalent human tapeworm. The prevalence statement is introductory, not a result.

32. 32
    Ito A, Onitake K, Sasaki J, Takami T. Hymenolepis nana: immunity against oncosphere challenge in mice previously given viable or non-viable oncospheres of H. nana, H. diminuta, H. microstoma and Taenia taeniaeformis.Int J Parasitol · 1991 · 21(2):241-5doi:10.1016/0020-7519(91)90015-y · PMID 1869358

    Mice without a thymus showed no resistance to new larvae, and eosinophils gathered around larvae in the villi of normal mice. Animal evidence for why T-cell loss matters.

33. 33
    Asano K, Taki M, Matsuo S, Yamada K. Mode of action of FK-506 on protective immunity to Hymenolepis nana in mice.In Vivo · 1996 · 10(6):537-45PMID 8986461

    Tacrolimus, a transplant drug, suppressed protective immunity to reinfection in mice at 10 mg/kg but not 5 mg/kg. Mouse data only.

34. 34
    Khalil HM, el Shimi S, Sarwat MA, et al. Recent study of Hymenolepis nana infection in Egyptian children.J Egypt Soc Parasitol · 1991 · 21(1):293-300PMID 2033304

    Praziquantel cured 91.1-97.7% and mebendazole 50-59% of 200 Egyptian children. A low-visibility regional journal; the morbidity figures in the same abstract have no comparison group and are not used here.

35. 35
    Safi N, Warusavithana S, Shah Alawi SA, et al. Elimination of morbidity due to soil-transmitted helminthiases among Afghan schoolchildren.Acta Trop · 2019 · 197:105035doi:10.1016/j.actatropica.2019.05.026 · PMID 31128094

    A WHO-led survey of 2,263 Afghan pupils after years of deworming: 6.8% carried the dwarf tapeworm.

36. 36
    Crompton DW. How much human helminthiasis is there in the world?J Parasitol · 1999 · 85(3):397-403PMID 10386428

    A 1999 review compiling worldwide estimates of worm infections, cited here as the probable origin of the global figures later papers repeat. PubMed holds no abstract and no DOI, and its tables were not read for this page, so its figures for the dwarf and beef tapeworms are not reported here and the attribution of the 50 to 75 million figure to it is not confirmed.

37. 37
    Scholz T, Garcia HH, Kuchta R, Wicht B. Update on the human broad tapeworm (genus diphyllobothrium), including clinical relevance.Clin Microbiol Rev · 2009 · 22(1):146-60doi:10.1128/CMR.00033-08 · PMID 19136438

    The fish tapeworm review: up to 20 million people estimated infected. An estimate, not a survey.

38. 38
    Saratsis A, Sotiraki S, Braae UC, et al. Epidemiology of Taenia saginata taeniosis/cysticercosis: a systematic review of the distribution in the Middle East and North Africa.Parasit Vectors · 2019 · 12(1):113doi:10.1186/s13071-019-3339-5 · PMID 30876439

    Beef tapeworm across 21 countries: microscopy-based prevalence 0.02-8.6%. Regional, and it does not give a global total.

39. 39
    Köller T, Hahn A, Altangerel E, et al. Comparison of commercial and in-house real-time PCR platforms for 15 parasites and microsporidia in human stool samples without a gold standard.Acta Trop · 2020 · 207:105516doi:10.1016/j.actatropica.2020.105516 · PMID 32371221

    On the same stool DNA, dwarf tapeworm was found 10 to 40 times as often as Taenia, with near-perfect agreement between platforms. The samples were chosen because they were likely infected, so these are not prevalences. One author is employed by a PCR reagent company. Inter-assay agreement for Taenia was poor (kappa below zero), so the Taenia counts, and the ratio built on them, are the least reliable figures in the study.

40. 40
    Mahamud MA, Ali Isse N, Ali AA, et al. Infections of Dwarf Tapeworm [Hymenolepis nana] (Cestoda: Hymenolepididae) and Its Associated Risk Factors Among Internally Displaced Children in Deynile District, Mogadishu, Somalia.J Parasitol Res · 2026 · 2026:1526083doi:10.1155/japr/1526083 · PMID 42052558

    27.08% of 384 children in two camps for displaced people in 2024, by a single wet mount. Convenience sample.

41. 41
    Willcocks B, McAuliffe GN, Baird RW. Dwarf tapeworm (Hymenolepis nana): Characteristics in the Northern Territory 2002-2013.J Paediatr Child Health · 2015 · 51(10):982-7doi:10.1111/jpc.12885 · PMID 25940598

    Twelve years of laboratory diagnoses in a high-income country: 461 episodes, predominantly in Indigenous children under five (median age 3.0), unchanged despite deworming. Laboratory-based, so it counts diagnoses, not prevalence.

42. 42
    Kappus KK, Juranek DD, Roberts JM. Results of testing for intestinal parasites by state diagnostic laboratories, United States, 1987.MMWR CDC Surveill Summ · 1991 · 40(4):25-45PMID 1779956

    CDC tally of 216,275 stool specimens examined by US state diagnostic laboratories in 1987: parasites in 20.1%, Hymenolepis nana 0.4%, Taenia 0.1%, Strongyloides 0.4%. A laboratory series of specimens sent for testing, not a population survey; the abstract does not name the methods. No DOI in the PubMed record.

43. 43
    La N, Leng M, Rattanapitoon K, et al. Intestinal parasitic infections and risk factors among the population in Cambodia.Trop Biomed · 2022 · 39(4):539-546doi:10.47665/tb.39.4.009 · PMID 36602213

    366 fecal specimens from Kratie Province and Phnom Penh, 2019 to 2021, by formalin-ethyl acetate concentration: Hymenolepis nana 1.09% against 0.54% for Taenia spp. A small sample; it counts both tapeworms on the same specimens.

44. 44
    Sharifi-Sarasiabi K, Heydari-Hengami M, Shokri A, HosseyniTeshnizi S. Prevalence of intestinal parasitic infection in food handlers of Iran: A systematic review and meta-analysis.Vet Med Sci · 2021 · 7(6):2450-2462doi:10.1002/vms3.590 · PMID 34358411

    25 Iranian studies of food handlers pooled: Hymenolepis nana 2.0% (95% CI 1.0 to 3.0) and Taenia spp. 2.0% (95% CI 0.0 to 7.0), a tie. Pooled estimates from heterogeneous studies of one occupational group.

45. 45
    Abd-Elrahman MZ, Sayed AS, Younes DA, et al. Morphological and molecular identification of Hymenolepis spp. in Rattus rattus and children with diarrhea from Upper Egypt.J Infect Dev Ctries · 2024 · 18(10):1601-1609doi:10.3855/jidc.18462 · PMID 39616491

    28.3% of 120 children with diarrhea, found by three ordinary microscopy methods and confirmed by PCR. A symptomatic, not general, population.

46. 46
    Wu SM, Gupta SS, Ravelomanantsoa MA, et al. Prevalence of multiple human intestinal parasites across diverse environments in Madagascar.PLoS Negl Trop Dis · 2026 · 20(6):e0014380doi:10.1371/journal.pntd.0014380 · PMID 42241434

    3,872 people in 31 communities: dwarf tapeworm up to 10.5%, most common in dry regions. Microscopy.

47. 47
    Reynoldson JA, Behnke JM, Pallant LJ, et al. Failure of pyrantel in treatment of human hookworm infections (Ancylostoma duodenale) in the Kimberley region of north west Australia.Acta Trop · 1997 · 68(3):301-12doi:10.1016/s0001-706x(97)00106-x · PMID 9492915

    A hookworm trial whose baseline survey found the dwarf tapeworm in 54.6% of 108 people in one Aboriginal community. One community.

48. 48
    Chernet A, Neumayr A, Hatz C, et al. Spectrum of infectious diseases among newly arrived Eritrean refugees in Switzerland: a cross-sectional study.Int J Public Health · 2018 · 63(2):233-239doi:10.1007/s00038-017-1034-x · PMID 28924741

    Stool microscopy found dwarf tapeworm eggs in 10.3% of 107 asymptomatic refugees in Switzerland. Small sample; European, not American.

49. 49
    Lopez M, Morales ML, Konana M, et al. Kato-Katz and Lumbreras rapid sedimentation test to evaluate helminth prevalence in the setting of a school-based deworming program.Pathog Glob Health · 2016 · 110(3):130-4doi:10.1080/20477724.2016.1187361 · PMID 27376503

    Three stool samples from each of 1,083 Peruvian children: Kato-Katz found 77.7% and sedimentation 97.9% of dwarf tapeworm infections, against all tests combined. Sensitivity against a composite, not a true gold standard.

50. 50
    Dalai C, Beaven SW. Hymenolepis nana Causing Chronic Diarrhea in an Immunosuppressed Patient.Clin Gastroenterol Hepatol · 2021 · 19(5):e45doi:10.1016/j.cgh.2020.02.050 · PMID 32147596

    A diagnosis made at Olive View-UCLA Medical Center in California. No abstract is indexed, so no clinical details are taken from it.

51. 51
    Santamaría-Fríes M, Fajardo LF, Sogin ML, et al. Lethal infection by a previously unrecognised metazoan parasite.Lancet · 1996 · 347(9018):1797-801doi:10.1016/s0140-6736(96)91618-9 · PMID 8667924

    A man with HIV died of an abdominal mass that looked like a neoplasm; broad-range ribosomal DNA sequencing of the tissue pointed to a previously uncharacterized tapeworm. It is the first published case of its kind found here; it did not identify the species; the 2003 re-examination by overlapping authors appears to have identified it as the dwarf tapeworm [41].

52. 52
    Crouch EEV, Hollinger C, Zec S, McAloose D. Fatal [Hymenolepis nana] cestodiasis in a ring-tailed lemur ([Lemur catta]).Vet Pathol · 2022 · 59(1):169-172doi:10.1177/03009858211042580 · PMID 34493121

    A zoo lemur killed by disseminated dwarf tapeworm of 'highly unusual' appearance, confirmed by sequencing. An animal parallel to invasive disease; no claim of cancer. PubMed strips the names from the title.

53. 53
    Archer KR, Waeschenbach A, Griffin C, et al. Fatal Hymenolepis nana-associated visceral larva migrans in captive juvenile white-tailed antsangies (Brachytarsomys albicauda).J Comp Pathol · 2024 · 212:32-41doi:10.1016/j.jcpa.2024.05.005 · PMID 38971022

    Four captive Madagascan rodents with larvae spread to liver, lymph nodes and beyond, confirmed by sequencing. Shows the larva can leave the gut in an unusual host; animal data.

54. 54
    Goldschmidt B, Menezes RC, Alves LC. The chromosomes of Rodentolepis nana (Siebold, 1852) Spasskii, 1954 obtained from naturally infected mice conventionally maintained in a Brazilian laboratory animal house.Parasite · 2006 · 13(1):75-7doi:10.1051/parasite/2006131075 · PMID 16605071

    A karyotype study (2n = 12), cited only because its title carries the worm's full name and authorities: named by Siebold in 1852 and moved to Rodentolepis by Spasskii in 1954. PubMed's title misspells Brazilian.

55. 55
    Nagaty HF, Rifaat MA, Salem S. Clinical trials with 'yomesan' in Hymenolepis nana infection.J Trop Med Hyg · 1962 · 65:128-9PMID 14477930

    A report of clinical trials of niclosamide, sold as Yomesan, against the dwarf tapeworm. PubMed holds no abstract, so only the title, the date and the indexing are used.

56. 56
    Nkouawa A, Haukisalmi V, Li T, et al. Cryptic diversity in hymenolepidid tapeworms infecting humans.Parasitol Int · 2016 · 65(2):83-6doi:10.1016/j.parint.2015.10.009 · PMID 26537836

    A tapeworm from a Tibetan woman that was neither of the two species held to infect people. One case, identified by DNA alone.

57. 57
    Deplazes P, Eichenberger RM, Grimm F. Wildlife-transmitted Taenia and Versteria cysticercosis and coenurosis in humans and other primates.Int J Parasitol Parasites Wildl · 2019 · 9:342-358doi:10.1016/j.ijppaw.2019.03.013 · PMID 31338294

    Read in full. The authors reanalysed the 18S sequence published for the Pennsylvania patient with Hodgkin disease in the 2003 paper [41], found 99.7% identity with the Versteria sequence from a patient in Atlantic Canada, and concluded that the Pennsylvania case was the first documented human Versteria infection. Versteria is a tapeworm of mustelids, the weasel family. A review; PubMed strips the genus names from the title.

58. 58
    Soares Magalhães RJ, Fançony C, Gamboa D, et al. Extending helminth control beyond STH and schistosomiasis: the case of human hymenolepiasis.PLoS Negl Trop Dis · 2013 · 7(10):e2321doi:10.1371/journal.pntd.0002321 · PMID 24205412

    Read in full. A viewpoint built on an Angolan survey of 2,168 children: one dose of praziquantel stops most egg excretion, but eradication sometimes needs a 5- to 7-day course of niclosamide to kill adult worms as they emerge. Opinion and one survey.

59. 59
    Centers for Disease Control and Prevention. Clinical Care of Hymenolepiasis (Dwarf Tapeworm).CDC · accessed October 2026www.cdc.gov/hymenolepis/hcp/clinical-care/index.html

    US clinical guidance: praziquantel 25 mg/kg once is the treatment of choice; niclosamide is given for 7 days and is not available in the United States; nitazoxanide is given for 3 days. Read through search-index copies of the page; the CDC site itself could not be opened from here.

60. 60
    Rossignol JF, Maisonneuve H. Nitazoxanide in the treatment of Taenia saginata and Hymenolepis nana infections.Am J Trop Med Hyg · 1984 · 33(3):511-2doi:10.4269/ajtmh.1984.33.511 · PMID 6731683

    The first report of nitazoxanide against the dwarf tapeworm: 18 patients needed a double dose. Small and uncontrolled; the record carries no affiliations or funding statement, and the first author is affiliated in later papers with Romark Laboratories, which holds the US approval for nitazoxanide (PMID 34402654) [87][90].

61. 61
    Conn DB. Malignant Transformation of Hymenolepis nana in a Human Host.N Engl J Med · 2016 · 374(13):1293doi:10.1056/NEJMc1600490 · PMID 27028926

    A published letter on the 2015 case from the Harvard Museum of Comparative Zoology. PubMed holds no abstract, so what it argued is not reported here.

62. 62
    Muehlenbachs A, Mathison BA, Olson PD. Malignant Transformation of Hymenolepis nana in a Human Host.N Engl J Med · 2016 · 374(13):1293-4doi:10.1056/NEJMc1600490 · PMID 27028925

    The original authors' reply to the 2016 correspondence. No abstract is indexed; its content is not reported here.

63. 63
    Ramos-Martínez E, Rojas-Serrano J, García-Hernández O, et al. The immune response to Hymenolepis nana in mice decreases tumorigenesis induced by 7,12 dimethylbenz-anthracene.Cytokine · 2019 · 123:154743doi:10.1016/j.cyto.2019.154743 · PMID 31255915

    Mice infected before exposure to a skin carcinogen grew fewer and smaller tumors. Mouse data, 56 animals; it points the opposite way from the 2015 case and says nothing about people.

64. 64
    Barkati S, Gottstein B, Müller N, et al. First Human Case of Metacestode Infection Caused by Versteria sp. in a Kidney Transplant Recipient.Clin Infect Dis · 2019 · 68(4):680-683doi:10.1093/cid/ciy602 · PMID 30212859

    An invasive, tumor-like liver infection with regional and distant spread in a 53-year-old kidney-transplant recipient from Atlantic Canada, caused by a tapeworm larva of the genus Versteria. One case; no transformation of parasite cells is reported.

65. 65
    Autier B, Gangneux JP, Robert-Gangneux F. Evaluation of the Allplex GI-Helminth(I) Assay, the first marketed multiplex PCR for helminth diagnosis.Parasite · 2021 · 28:33doi:10.1051/parasite/2021034 · PMID 33812465

    A commercial helminth PCR panel that includes Hymenolepis, evaluated on 110 French samples; it needed mechanical disruption of the stool to stop missing them. Its regulatory status in the United States was not established here.

66. 66
    Miller JM, Binnicker MJ, Campbell S, et al. Guide to Utilization of the Microbiology Laboratory for Diagnosis of Infectious Diseases: 2024 Update by the Infectious Diseases Society of America (IDSA) and the American Society for Microbiology (ASM).Clin Infect Dis · 2024 · ciae104 (published online 5 Mar 2024)doi:10.1093/cid/ciae104 · PMID 38442248

    The current joint US guide to which tests to order. Only the abstract was retrievable; one author's listed affiliation is a diagnostics manufacturer, Cepheid.

67. 67
    Mijatović S, Štajner T, Čalovski IČ, et al. Human infections by Hymenolepis diminuta in Europe: a case report and literature review.Trans R Soc Trop Med Hyg · 2024 · 118(9):580-588doi:10.1093/trstmh/trae037 · PMID 38864212

    104 laboratory-confirmed European cases of the rat tapeworm: cleared with praziquantel or niclosamide, while albendazole or mebendazole gave unfavorable results. A literature review with one new case.

68. 68
    Garcia LS, Arrowood M, Kokoskin E, et al. Practical Guidance for Clinical Microbiology Laboratories: Laboratory Diagnosis of Parasites from the Gastrointestinal Tract.Clin Microbiol Rev · 2018 · 31(1):e00025-17doi:10.1128/CMR.00025-17 · PMID 29142079

    Consensus laboratory guidance for stool parasitology; the abstract says the methods are manual and need extensive bench experience. Its organism-level detail was not retrievable.

69. 69
    Branda JA, Lin TY, Rosenberg ES, et al. A rational approach to the stool ova and parasite examination.Clin Infect Dis · 2006 · 42(7):972-8doi:10.1086/500937 · PMID 16511762

    At Massachusetts General Hospital, the first stool specimen found 91% of the parasites detected, and one comprehensive O&P was judged enough for most patients. All parasites together, not dwarf tapeworm separately.

70. 70
    Rubio Maturana C, Sulleiro E, Zarzuela F, et al. Performance of the Techcyte AI-based image analysis system for coproparasitological diagnosis in clinical stool specimens: a retrospective evaluation study.J Clin Microbiol · 2026 · 64(8):e0043126doi:10.1128/jcm.00431-26 · PMID 42324608

    A hospital evaluation, in Barcelona, of a commercial artificial-intelligence reader for O&P slides: 96.62% agreement on positives with operator review. It concerns a proprietary product; dwarf tapeworm is not reported separately in the abstract.

71. 71
    Polage CR, Stoddard GJ, Rolfs RT, Petti CA. Physician use of parasite tests in the United States from 1997 to 2006 and in a Utah Cryptosporidium outbreak in 2007.J Clin Microbiol · 2011 · 49(2):591-6doi:10.1128/JCM.01806-10 · PMID 21106798

    At a national US referral laboratory, 76.0% of 170,671 parasite-testing episodes included an O&P. Shows the test was routinely used; its data end in 2006, before multiplex panels.

72. 72
    Chitsaz E, Rotcheewaphan S, Koh C, Heller T. "Dwarfing" White Strands on Screening Colonoscopy!Gastroenterology · 2018 · 155(3):e22-e23doi:10.1053/j.gastro.2018.04.022 · PMID 29702114

    A dwarf tapeworm found at screening colonoscopy at the National Institutes of Health in Bethesda. No abstract; only the indexing (a middle-aged man) is used.

73. 73
    Markham JL, Hall M, Collins ME, et al. Variation in stool testing for children with acute gastrointestinal infections.J Hosp Med · 2023 · 18(6):473-482doi:10.1002/jhm.13087 · PMID 36988413

    Across 37 US children's hospitals, 2016-2020, among otherwise healthy children with acute gastrointestinal infections: individual kinds of stool test in 0.1% to 2.3% of emergency-only encounters and 1.5% to 13.8% of hospitalizations; an O&P sent for under 10% of hospitalized children, ranging from 0% to 35.1% across hospitals (full text, PMC11340271). Its discussion summarizes the 2017 IDSA stool-testing recommendations.

74. 74
    Nagy M, Wychera C, Schemm J, et al. Bacterial and Parasitic Stool Studies Have Limited Utility in Pediatric Hematopoietic Stem Cell Transplant Patients.Pediatr Blood Cancer · 2025 · 72(5):e31617doi:10.1002/pbc.31617 · PMID 39979777

    At a Boston children's hospital, an O&P was sent for 10% of 1,381 transplant recipients and 2 of 242 were positive. Shows how seldom it is ordered and how seldom it is positive there; not specific to dwarf tapeworm.

75. 75
    Shane AL, Mody RK, Crump JA, et al. 2017 Infectious Diseases Society of America Clinical Practice Guidelines for the Diagnosis and Management of Infectious Diarrhea.Clin Infect Dis · 2017 · 65(12):e45-e80doi:10.1093/cid/cix669 · PMID 29053792

    The governing US guideline on infectious diarrhea. Only its abstract, a scope statement, was retrievable; its stool-testing recommendations are quoted here as summarized in [59], and its own wording on the O&P was not checked.

76. 76
    Asai T, Còrdova Vidal C, Strauss W, et al. Effect of Mass Stool Examination and Mass Treatment For Decreasing Intestinal Helminth and Protozoan Infection Rates in Bolivian Children: A Cross-Sectional Study.PLoS Negl Trop Dis · 2016 · 10(12):e0005147doi:10.1371/journal.pntd.0005147 · PMID 27923058

    Three yearly rounds of stool testing and nitazoxanide treatment in Bolivian children, with dwarf tapeworm falling from 9.0% to 3.4%. Repeated cross-sections without a control group.

77. 77
    Craig P, Ito A. Intestinal cestodes.Curr Opin Infect Dis · 2007 · 20(5):524-32doi:10.1097/QCO.0b013e3282ef579e · PMID 17762788

    Review: three genera, Taenia, Hymenolepis and Diphyllobothrium, cause most human intestinal tapeworm infections, which are usually mild and usually treated with one dose of praziquantel or niclosamide. It gives no comparative global counts in its abstract.

78. 78
    Gupta S, Katiyar JC. Comparative activity of anticestode drugs--praziquantel, niclosamide and Compound 77-6, against Hymenolepis nana.J Helminthol · 1983 · 57(1):31-6doi:10.1017/s0022149x00007847 · PMID 6841958

    In mice, praziquantel worked best and niclosamide worst in the living animal, the reverse of their effects in a dish. Animal and laboratory data only.

79. 79
    US Food and Drug Administration. Biltricide (praziquantel) tablets: Drugs@FDA application NDA 018714.Drugs@FDA · accessed October 2026www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=018714

    Praziquantel is approved in the United States for schistosomiasis and for clonorchiasis and opisthorchiasis, infections with liver flukes; no tapeworm is among its indications.

80. 80
    US Food and Drug Administration. Alinia (nitazoxanide) tablets and oral suspension: prescribing information (NDA 021497 and 021498).FDA label · Romark Laboratories · 2022www.accessdata.fda.gov/drugsatfda_docs/label/2022/021497s018,021498s019lbl.pdf

    Nitazoxanide is approved in the United States for diarrhea caused by Giardia lamblia or Cryptosporidium parvum; worms are not among its indications. Romark Laboratories holds the application.

81. 81
    Reigl LS, Lange IL, Okan O, et al. Tackling schistosomiasis in fisherfolk communities in Uganda: Enablers and challenges for implementing paediatric schistosomiasis mass drug administration from the perspective of district health authorities.Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz · 2025 · 68(7):778-786doi:10.1007/s00103-025-04066-w · PMID 40478256

    Describes arpraziquantel as a new child-friendly praziquantel formulation being introduced for schistosomiasis. It says nothing about the dwarf tapeworm.

82. 82
    Stachulski AV, Rossignol JF, Pate S, et al. Synthesis, antiviral activity, preliminary pharmacokinetics and structural parameters of thiazolide amine salts.Future Med Chem · 2021 · 13(20):1731-1741doi:10.4155/fmc-2021-0055 · PMID 34402654

    Cited only for its affiliations: J.F. Rossignol, first author of the 1984 nitazoxanide report [45], is listed at Romark Laboratories, LC, Tampa, the company that holds the US approval for nitazoxanide [90].

83. 83
    Soriano V, Barreiro P. Non-Human Cancers in AIDS Patients.AIDS Rev · 2015 · 17(4):238-9PMID 26690493

    A short news commentary written about the 2015 case, placing it beside the virus-driven cancers of HIV. Commentary, not data; the indexed abstract is truncated.

84. 84
    Buttenschoen J, Kowalewska-Grochowska K, Kleinman D, et al. First human infection and management of Versteria rafei infection restricted to the liver with phylogenetic analysis in the context of known cases.Lancet Infect Dis · 2025 · 25(12):e730-e737doi:10.1016/S1473-3099(25)00281-6 · PMID 40544860

    A case of Versteria rafei confined to the liver, with a review of known cases, which the authors say typically occur in immunosuppressed hosts and quickly involve several organs without treatment. Case report and review; no transformation of parasite cells is reported.

85. 85
    Kikuchi T, Maruyama H. Human proliferative sparganosis update.Parasitol Int · 2020 · 75:102036doi:10.1016/j.parint.2019.102036 · PMID 31841658

    The other tapeworm whose larva multiplies through human tissue, and a warning that some old cases were the wrong tapeworm: sequencing is required for diagnosis. A different organism and a different disease.

86. 86
    Biological agents.IARC Monogr Eval Carcinog Risks Hum · 2012 · 100(Pt B):1-441PMID 23189750

    The International Agency for Research on Cancer's review of infectious carcinogens; its PubMed indexing names three fluke infections and no tapeworm. No abstract is indexed.

87. 87
    de Martel C, Georges D, Bray F, et al. Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis.Lancet Glob Health · 2020 · 8(2):e180-e190doi:10.1016/S2214-109X(19)30488-7 · PMID 31862245

    2.2 million cancers in 2018 were attributed to ten infections classed as carcinogens, led by H. pylori and HPV. It is the scale against which a single tapeworm case should be read.

88. 88
    Koziol U, Rauschendorfer T, Zanon Rodríguez L, et al. The unique stem cell system of the immortal larva of the human parasite Echinococcus multilocularis.EvoDevo · 2014 · 5(1):10doi:10.1186/2041-9139-5-10 · PMID 24602211

    In a related tapeworm, undifferentiated germinative cells are the only cells that divide. Used here for biological plausibility only; it is not about the dwarf tapeworm or about cancer.

89. 89
    Tsai IJ, Zarowiecki M, Holroyd N, et al. The genomes of four tapeworm species reveal adaptations to parasitism.Nature · 2013 · 496(7443):57-63doi:10.1038/nature12031 · PMID 23485966

    Tapeworm genomes, including the laboratory Hymenolepis species, have lost several genes that govern stem cell fate. Genomic description; it does not test any cancer hypothesis.

90. 90
    Cui X, Cheng Y, Wang H, et al. Hymenolepis nana antigens alleviate ulcerative colitis by promoting intestinal stem cell proliferation and differentiation via AhR/IL-22 signaling pathway.PLoS Negl Trop Dis · 2024 · 18(12):e0012714doi:10.1371/journal.pntd.0012714 · PMID 39666730

    In mice with chemically induced colitis and in intestinal organoids, worm antigens eased the colitis and stimulated intestinal stem-cell proliferation. Mouse and organoid data only.

91. 91
    Mou R, Cui X, Wang H, et al. Excretory/secretory products from Hymenolepis nana adult worms alleviate ulcerative colitis in mice via tuft/IL-13 signaling pathway.Parasit Vectors · 2025 · 18(1):230doi:10.1186/s13071-025-06893-x · PMID 40542404

    Adult-worm secretions improved chemically induced colitis in mice and promoted intestinal stem-cell proliferation and differentiation. Same group as [84]; mouse and organoid data only.

92. 92
    Mou R, Cui XY, Luo YS, et al. Adult Hymenolepis nana and its excretory-secretory products elicit mouse immune responses via tuft/IL-13 and FOXM1 signaling pathways.Parasit Vectors · 2025 · 18(1):100doi:10.1186/s13071-025-06719-w · PMID 40069907

    Adult worms and their secretions increased tuft, goblet and Paneth cells and supported intestinal stem-cell proliferation and differentiation in mice. Same group as [84]; mouse data only.

93. 93
    Oberli A, Furrer L, Skoko L, Müller N, Gottstein B, Bittel P. A novel multiplex real-time polymerase chain reaction for the molecular diagnosis of metacestode infections in human patients.Clin Microbiol Infect · 2023 · 29(11):1451.e1-1451.e5doi:10.1016/j.cmi.2023.07.032 · PMID 37544608

    A Swiss validation of a real-time PCR for larval tapeworm infections in biopsy and cytology material. It detected Hymenolepis species, Versteria and other non-echinococcal larvae, and for its three main targets had a lower detection limit than conventional PCR; detection limits were not reported for Hymenolepis itself.